Design, synthesis, and biological activity of 1,2,3-Triazolobenzodiazepine BET Bromodomain inhibitors
Details
Publication Year 2017-12-14, Volume 8, Issue #12, Page 1298-1303
Journal Title
ACS Med Chem Lett
Publication Type
Journal Article
Abstract
A number of diazepines are known to inhibit bromo- and extra-terminal domain (BET) proteins. Their BET inhibitory activity derives from the fusion of an acetyl-lysine mimetic heterocycle onto the diazepine framework. Herein we describe a straightforward, modular synthesis of novel 1,2,3-triazolobenzodiazepines and show that the 1,2,3-triazole acts as an effective acetyl-lysine mimetic heterocycle. Structure-based optimization of this series of compounds led to the development of potent BET bromodomain inhibitors with excellent activity against leukemic cells, concomitant with a reduction in c-MYC expression. These novel benzodiazepines therefore represent a promising class of therapeutic BET inhibitors.
Publisher
ACS
WEHI Research Division(s)
Chemical Biology; Cancer And Haematology; Systems Biology And Personalised Medicine; Bioinformatics; Structural Biology
PubMed ID
29259751
Rights Notice
Refer to copyright notice on published article.


Creation Date: 2018-01-15 12:39:46
Last Modified: 2018-01-15 12:41:48
An error has occurred. This application may no longer respond until reloaded. Reload 🗙